Tandem Diabetes downgraded to Market Perform from Outperform at Bernstein
Bernstein downgraded Tandem Diabetes (TNDM) to Market Perform from Outperform with a price target of $25, down from $35. The firm notes Tandem ...
Insulet's Distinctive Omnipod Pump Makes Inroads With Large Type 2 Diabetes Segment
Until Insulet's Omnipod came on the market at the end of 2005, all insulin pumps consisted of a controller and insulin reservoir attached to the injection site by a long flexible tube. The Omnipod ...
drugdeliverybusiness29d
Modular Medical takes step forward in CE mark process for insulin pump tech
The MODD1 insulin pump. [Image from Modular Medical] Modular Medical (Nasdaq:MODD) announced that BSI Group will serve as the notified body for its European regulatory process. This marks a step ...